skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Improve your clinical trial decisions and cycle times


Have you ever had a clinical trial impacted by under-performing clinical trial sites?  Have you ever had to quickly mitigate risk when the time, cost, or resource required for study start-up differs from expectations?

What if you could accurately identify quality sites based on a combination of factors and understand the impact of selected sites on predicted enrollment timelines and durations?



Introducing Citeline Study Feasibility


Be one of the first to benefit from industry-leading technology that will help you:

  • Accelerate your clinical trial timelines
  • Select more sites that successfully enroll patients
  • Optimize your feasibility scenarios faster, with better outcomes and with less effort than ever before


About Citeline Study Feasibility

Citeline Study Feasibility is a platform that combines subject matter expertise and machine-learning to develop predictive insights for feasibility planning.  We are accelerating clinical trial timelines by bringing together our technical/machine-learning capabilities with our expertly curated, best-in-class clinical data sets, which are built on standardized ontologies and enriched by domain knowledge and natural language processing (NLP).


In a single platform, these predictive insights can be modeled and optimized with explain-ability and transparency:  


  • Site scoring
  • Recommended country-site allocation
  • Enrollment prediction, with probability of enrollment success 

Strategic Study Feasibility.1

Why Citeline Study Feasibility?

There are 4 major expected business benefits for clients who use Citeline Study Feasibility:


  • Accelerate trial enrollment and speed to patient by improving cycle times and selecting more sites that successfully enroll patients
  • Select countries and sites that maximize enrollment potential
  • Model, compare, and optimize global feasibility scenarios faster, with better outcomes and with less effort
  • Make better decisions and know why they are better: Transparently understand what features of a clinical trial are having a positive or negative impact on predicted enrollment duration


Our data science approach combines advanced machine-learning with gold-standard data, resulting in a powerful solution that is far superior to traditional approaches for clinical trial feasibility




Register your interest today to be one of the first to benefit from Citeline Study Feasibility

Register your interest


Read also

  • Pharma R&D 2021

    Introduction Welcome to Pharmaprojects’ 2021 review of trends in pharmaceutical R&D. For almost 30 years now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article I’ll examine the state of play at the start of 2021. 

    Topics Drug Review

  • China Clinical Trials Landscape

    In 2017, Informa Pharma Intelligence took a deep dive into the clinical trial landscape in China over the previous 10 years, in a whitepaper entitled “Is China the Dark Horse in Clinical Development?”. That analysis showed that the number of trial starts in China had been trending upwards year-on-year and suggested that China was on course to become a formidable player within the pharma industry on a global stage.

    Topics Clinical Trials

  • 6th Annual Citeline Awards 2021 Finalists Revealed

    Informa Pharma Intelligence reveals the shortlist for excellence in clinical research and development


Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: